Verve Therapeutics (NASDAQ:VERV) stock gains as the company wins the FDA fast track designation for VERVE-102, a cholesterol ...

CHICAGO, IL—An investigational agent given by subcutaneous injection can drastically reduce levels of lipoprotein (a), with ...

Verve Therapeutics (VERV) announced that the U.S. Food and Drug Administration, FDA, has granted Fast Track designation for VERVE-102 for the ...

Heart experts have shared foods that could help offer similar effects to statins, such as being able to lower cholesterol ...

A new drug in clinical trials is showing promise in lowering a key genetic risk factor for heart attacks and ...

Chemist Dr Tim Bond has listed five essential oils linked to lower cholesterol, weight loss and reduced inflammation ...

Berberine is a powder made from different plants. It has many benefits, including improving blood sugar levels, reducing ...

In addition, in the second half of 2025, Verve remains on track to report the final data for the dose escalation portion of the Heart-2 clinical trial, deliver the opt-in package for the PCSK9 program ...

Joseph Saseen, PharmD, discussed the importance of knowing lipoprotein a (Lp[a]) levels to enable clinicians to provide the ...

In people with HIV taking antiretroviral therapy, excessive visceral abdominal fat drives cardiovascular disease risk, even ...

A single dose of an siRNA molecule reduces elevated lipoprotein(a) — a major, but to date, largely untreatable risk factor ...

An energy-restricted Mediterranean diet plus physical activity can mitigate weight loss and age-related decline in bone ...